E³ - Advanced Course: Hybrid Imaging
E³ 1119 - Guidelines and cost-effectiveness
Lectures
1
Chairperson's introduction
05:00Wolfgang Gerhard Kunz, Munich / DE
2
PET/CT in lymphoma: guidelines
23:00Manil Subesinghe, London / UK
3
PET/CT in lung cancer: guidelines
23:00Wolfgang Gerhard Kunz, Munich / DE
4
Cost-effectiveness of hybrid imaging
20:00Wolfgang Gerhard Kunz, Munich / DE
5 min
Chairperson's introduction
Wolfgang Gerhard Kunz, Munich / Germany
23 min
PET/CT in lymphoma: guidelines
Manil Subesinghe, London / United Kingdom
- To summarise recommendations for staging and response assessment of lymphoma with FDG PET-CT as outlined in the Lugano classification.
- To confidently apply the 5-point scale (5-PS), i.e. Deauville criteria, when reporting response assessment FDG PET-CT.
- To demonstrate an understanding of the pitfalls of FDG PET-CT interpretation in lymphoma and their potential impact on clinical management.
23 min
PET/CT in lung cancer: guidelines
Wolfgang Gerhard Kunz, Munich / Germany
- To identify the current value of FDG PET/CT for treatment decisions in lung cancer.
- To list the current position of FDG PET/CT in the current guidelines.
20 min
Cost-effectiveness of hybrid imaging
Wolfgang Gerhard Kunz, Munich / Germany
- To understand the basics of cost-effectiveness analysis.
- To learn about the public health impact of hybrid imaging.
- To get familiar with the cost-effectiveness of contemporary hybrid imaging.
16 min
Panel discussion: Where is the money, honey?